வானலை உயிர் அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from வானலை உயிர் அறிவியல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In வானலை உயிர் அறிவியல் Today - Breaking & Trending Today

Cell and Gene Therapy Innovator Castle Creek Biosciences Appoints Matthew Gantz as President and Chief Executive Officer


Cell and Gene Therapy Innovator Castle Creek Biosciences Appoints Matthew Gantz as President and Chief Executive Officer
- Life sciences executive brings more than 25 years of experience to cell and gene therapy company progressing through pivotal Phase 3 clinical trial -
News provided by
Share this article
Share this article
EXTON, Pa., April 20, 2021 /PRNewswire/  Castle Creek Biosciences, Inc. (the Company ), a privately held, clinical-stage cell and gene therapy company leveraging its proprietary fibroblast technology platform to develop and commercialize disease-modifying therapies for patients suffering from orphan conditions for which there is a lack of available treatment options, today announced that Matthew Gantz has been appointed President and Chief Executive Officer. He will also serve as a member of the Company s Board of Directors. Mr. Gantz succeeds John Maslowski, who will continue to serve the company as Chief Operating Officer. ....

United States , Matthew Gantz , Adam Daley , Karen Casey , Jeff Aronin , John Maslowski , Emalex Biosciences , Company Board Of Directors , Princeton University , Marine Corps Scholarship Foundation , Harvard Business School , Castle Creek Biosciences Inc , Berry Company Public Relations , Chiron Corporation , Acureon Pharmaceuticals Inc , Abbott Laboratories , Harmony Biosciences Holdings , Pathogenesis Corporation , Paragon Biosciences , Castle Creek Biosciences , Chief Executive , Chief Operating , Castle Creek , Paragon Bioscience , Chief Executive Officer , Acureon Pharmaceuticals ,

Paragon Biosciences Appoints Jordan Dubow as Chief Medical Officer


Paragon Biosciences Appoints Jordan Dubow as Chief Medical Officer
News provided by
Share this article
Share this article
CHICAGO, Feb. 23, 2021 /PRNewswire/  With continued growth in its portfolio of life science companies, Paragon Biosciences announced the appointment of Jordan Dubow, M.D., as chief medical officer. Dr. Dubow is responsible for identifying and evaluating innovation opportunities utilizing his clinical and regulatory expertise and providing guidance to Paragon s seven portfolio companies. Headquartered in Chicago, Paragon Biosciences is a life science innovator that creates, invests in and builds life science companies in biopharmaceuticals, cell and gene therapy and synthetic biology utilizing artificial intelligence. ....

United States , Jeff Aronin , Evelynm Oconnor , Emalex Biosciences , Therapeutic Strategy At Esteve Pharmaceuticals , Avadel Pharmaceuticals , York Presbyterian Weil Cornell Medical Center , Northwestern University Feinberg School Of Medicine , Paragon Biosciences , Jordan Dubow , Esteve Pharmaceuticals , Cynapsus Therapeutics , Northwestern University Feinberg School , Northwestern University Affiliated , New York , Weil Cornell Medical , Castle Creek Biosciences , Harmony Biosciences , Qlarity Imaging , Skyline Biosciences , Paragon Innovation Capital , ஒன்றுபட்டது மாநிலங்களில் , யார்க் ப்ரெஸ்பிடீரியந் வெயில் கார்னெல் மருத்துவ மையம் , வடமேற்கு பல்கலைக்கழகம் ஃபைன்பெர்க் பள்ளி ஆஃப் மருந்து , பாராகான் உயிர் அறிவியல் , ஜோர்டான் துபோவ் ,